Protara Therapeutics, Inc. (TARA)
3.905
+0.04
(+1.17%)
USD |
NASDAQ |
Sep 01, 16:00
3.905
0.00 (0.00%)
After-Hours: 17:02
Protara Therapeutics Net Income (TTM) : -70.02M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -70.02M |
| March 31, 2026 | -63.31M |
| December 31, 2025 | -57.44M |
| September 30, 2025 | -52.90M |
| June 30, 2025 | -50.86M |
| March 31, 2025 | -45.42M |
| December 31, 2024 | -44.60M |
| September 30, 2024 | -42.05M |
| June 30, 2024 | -40.69M |
| March 31, 2024 | -42.47M |
| December 31, 2023 | -40.42M |
| September 30, 2023 | -69.17M |
| June 30, 2023 | -67.00M |
| March 31, 2023 | -64.24M |
| December 31, 2022 | -65.95M |
| September 30, 2022 | -37.21M |
| June 30, 2022 | -40.30M |
| March 31, 2022 | -44.54M |
| December 31, 2021 | -47.25M |
| September 30, 2021 | -45.83M |
| June 30, 2021 | -43.02M |
| March 31, 2021 | -37.38M |
| December 31, 2020 | -33.98M |
| September 30, 2020 | -27.69M |
| June 30, 2020 | -22.07M |
| Date | Value |
|---|---|
| March 31, 2020 | -16.36M |
| December 31, 2019 | -7.83M |
| September 30, 2019 | -10.57M |
| June 30, 2019 | -12.73M |
| March 31, 2019 | -16.18M |
| December 31, 2018 | -20.73M |
| September 30, 2018 | -21.02M |
| June 30, 2018 | -28.82M |
| March 31, 2018 | -29.55M |
| December 31, 2017 | -29.96M |
| September 30, 2017 | -31.38M |
| June 30, 2017 | -26.18M |
| March 31, 2017 | -28.47M |
| December 31, 2016 | -28.53M |
| September 30, 2016 | -27.91M |
| June 30, 2016 | -26.18M |
| March 31, 2016 | -23.35M |
| December 31, 2015 | -21.38M |
| September 30, 2015 | -7.802M |
| June 30, 2015 | -7.60M |
| March 31, 2015 | -5.091M |
| December 31, 2014 | -3.342M |
| September 30, 2014 | -12.68M |
| June 30, 2014 | -9.044M |
| March 31, 2014 | -8.346M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| NovelStem International Corp. | -0.3076M |
| Brainstorm Cell Therapeutics, Inc. | -10.52M |
| Summit Therapeutics, Inc. | -856.09M |
| Kezar Life Sciences, Inc. | -45.23M |
| Clene, Inc. | -39.52M |